Home
Journals
A-Z Journals
Browse By Subject
Guidelines & Policies
Editorial Policies
Online Submission
Instructions to Authors
Policies
Publication ethics & malpractice statement
Reviewers
Terms and Conditions
Advertising
Conferences
Contact us
Immunotherapy: Open Access
Open Access
ISSN: 2471-9552
Journal Home
Editorial Panel
Editor-in-Chief
Editorial Board
Instructions for Authors
Instructions for Authors
Publication ethics & malpractice statement
Submit Manuscript
Aims and Scope
Articles in process
Special Issue
Archive
Contact
Review Article - (2015) Volume 1, Issue 1
View PDF
Download PDF
Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?
Asifa Zaidi
,
Qinglai Meng
*
and
Daniel Popkin
Department of Dermatology,
Case Western Reserve University
School of Medicine, Cleveland, OH 44106, USA
*
Corresponding Author:
Qinglai Meng, Department of Dermatology,
Case Western Reserve University
School of Medicine, Cleveland, OH 44139, USA, Tel: 216-368-1303
Email:
Abstract